It seems to me we have been anticipating the FDA's assessment of CSL112 for the best part of 2 decades...I'd like to think CSL would have pulled the plug on this potential blockbuster long before now if they were not pretty convinced that CSL112 will quickly become the standard-of-care therapy for the misfortunate folks who suffer a heart attack.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$255.31 |
Change
-2.070(0.80%) |
Mkt cap ! $123.6B | |||
| Open | High | Low | Value | Volume |
| $256.32 | $256.50 | $252.60 | $171.9M | 674.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6 | $255.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $255.83 | 104 | 1 |
View Market Depth
| Last trade - 16.14pm 21/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |